Abstract View

Author(s): Pratiksha S. Behare*1, Sakshi V. Patil2, Dipali S. Chaudhari3, Devesh P. Bhavsar Akanksha B. Pardhi4

Email(s): 1beharepratiksha15@gmail.com

Address:

    Khandesh Education Society's Late Shri. Pandharinath Chhagansheth Bhandarkar College of D. Pharmacy & Late Prof R. K. Kele College of B. Pharmacy, Amalner- 425401 Dist-Jalgaon (M.S.) India

Published In:   Volume - 3,      Issue - 6,     Year - 2024

DOI: Not Available

 View HTML        View PDF

Please allow Pop-Up for this website to view PDF file.

ABSTRACT:
Breast cancer is a leading cause of death in women worldwide, and better treatments are needed. This study focuses on how nanotechnology is changing breast cancer care by improving drug delivery, more precisely targeting cancer cells, and reducing harmful side effects. Nanoparticles, such as gold-based polymers, carbon-based polymers, liposomes, and engineered nanoparticles, hold great promise for addressing current treatment challenges, such as drug resistance and damage to healthy tissue. These tiny particles help drugs reach cancer cells more effectively, stay active in the body longer, and cause fewer side effects. They are also being used in new ways, including in imaging, photothermal therapy, and combination treatments with other therapies such as immunotherapy. Advances in nanoparticle design, such as the addition of special molecules that target cancer cells, are making treatments even more precise. But challenges such as production, safety and approval processes need to be addressed. This review highlights the latest research, patents and studies that show that nanoparticles could play a key role in the future treatment of breast cancer.

Cite this article:
Pratiksha S. Behare, Sakshi V. Patil, Dipali S. Chaudhari, Devesh P. Bhavsar Akanksha B. Pardhi. Current Drug Development and Therapeutic Insight of Breast Cancer Treatment. IJRPAS; 3(6): 55-63


 [1] About Breast cancer.American cancer society.1-13

[2] Fanfair D,Desai S,Kelty C.The early history of nanotechnology.connexions module 2007., 2

[3] Roco M.C. Nanoparticles and Nanotechnology research.Journal of nanoparticle research,1.1999.2

[4] Khan I . Nanoparticles:properties,applicationsand toxicities.Arabian journal of chemistry 2019.909-910

[5] Gaberial A.Introduction to nanotechnology and its application to medicine.surg neurol2004,216-217

[6] Yezhelyev m.v, Gao X, Xing Y, Haji A.Al, Nie 5,0 'Regan R.m, Emerging use of nanoparticles in diagonsis and treatment of breast cancer", Lancet oncol 2006, 7. 657

[7] " Yoo Y, Zhou y, liu L, Xu y. Chen Q, Wang y, wu shijie, Deng Y, Zhang J, Shao A. Nanoparticle – Based Drug Delivery in cancer Therapy. and Its Role in Overcoming Drug Resistance frontiers In molecular Biosciences, 20 ,2020,  5

[8] Oechler J.B, Rajapraksha w. Albrech H, "Emerging Applications of Nanoparticles in the Diagnosis and Treatment Breast cancer", Journal of Personalized medicine, 7.

[9] Ochler J.B. Rajapaksha w., Albrech H, "Emerging Applications of Nanoparticles in the Treatment Breast cancer",Journel of Personalized medicine , 2024, 2

[10] chaudhari A, Kumar D.N. Shaik R.A. Eid B.G, Abdel - Nai'm A.B. My shudab, Ahmad A. Agrawal A.K, "Lipid Based Nanoparticles a Pivotul delivery Approach in Triple negative Breast cancer (TBNC) Therapy ,International Journal of Molecular Sciences, 2022,7-8.

[11] Ali S, Z Qizilbash, FF, Anna Md, S Alhakamy, N.A. Baboota, 5. Ali, 1. Iblymuric  . Polymeric Nanoparticles: Exploring the Current Drug Development and Therapeutic Insight of Breast Cancer Treatment and Recommendations,MDPI.2021,6

[12] Lee J., chatterjee D, Lee M., Krinchnan S Gold .nanoparticles in breast cancer treatment". promise and potential pitfalls, NIH Public Access ,Aug 2024,2

[13] Solanki R., Rajput P., Jodha B., Yadav U., patel s., enhancing apoptosis mediated anticancer activity of evodianine through protein-based nanoparticles in breast cancer cells, nature portfolio 2024, 14, 2

[14] Bianco A, Kastorelos K, Prato M., "Opportunitiesande hallenges of carbon-based nanomaterials for cancer therapy. Expert Opinion Drug Delivery, 2008, 332- 333

[15] Rajana M., Aare M., Padakanti S., Valamla B., Urati A, khatri D., Sigh S., Mehra M., Multifuncional hybrid nanoparticles in diagnosis & therapy of breast cancer, Journal of controlled release, Dec 2022, 352, 2

[16] Grewal I., singh s, Arora s., sharme N, polymeric nanoparticles for breast cancer Therapy! A comprehensive review, Biointerface Research in applied chemistry 2021, 11, 11153

[17] Erin zaluzec, Lorenzo S., systemic and Local Steratergies for primary prevention of Breast cancer, Cancers 2024, 16, 1-2

[18] Kumar G., Yan w, fei G, Deng L, Jiapeng C., Targeting engineemed nanoparticles for Breast cancer Therapy, pharmaceutics, 2021, 13, 21 & 22

Related Images:



Recent Images



Assessing Philippine Health Care Coverage Gaps: An Assessment of Accessibility of Public Health Programs in Selected Barangay in Imus, Cavite, Philippines
Isoabsorptive UV Spectrophotometry Method development and validation for simultaneous estimation of Eslicarbazepine Acetate and Carbamazepine
To develop and validate the stability indicating method for repaglinide and voglibose using HPLC method
To develop and validate the stability indicating method for Empagliflozin and Linagliptin using HPLC method
A Prospective Observational Study on the Clinical Evaluation of Vertigoin Young Adult Population of Amaravati Capital Region
Quality by Design-Based Analytical Method Development and Validation of Suzetrigine by RP - HPLC
Formulation, Optimization and Evaluation of Rimegepant Pulsatile Tablets for Chronotherapeutic Management of Migraine
Development and Evaluation of Ticagrelor Solid Dispersion Tablets Using PVP K30, PEG 6000 and HPMC E5 for Dissolution Enhancement
To study the effect of various superdisintegrants and binders in the Formulation and Evaluation of Labetalol Rapid Disintegrating Tablet
To Develop and Validate the Stability Indicating Method for Ezetimibe and Rosuvastatin Using HPLC Method

Tags